Sfoglia per Rivista  

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 15 a 34 di 41
Titolo Data di pubblicazione Autore(i) File
Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis: an emerging issue. 1-gen-2002 Bruno, R; Sacchi, P; Filice, C; Puoti, Massimo; Filice, G.
HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations 1-gen-2004 Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Monno, L; Patroni, Andrea; Saracino, A; Angarano, G; Tinelli, C; Mazzotta, F; Lo Caputo, S; Pierotti, P; Carosi, Giampiero; GenPheRex PhenGen Study Groups of the MASTER, Cohort
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER Cohort. 1-gen-2006 Torti, Carlo; Lapadula, Giuseppe; Puoti, Massimo; Casari, Salvatore; Uccelli, Mc; Cristini, G; Bella, D; Pastore, G; Ladisa, N; Minoli, L; Sotgiu, G; Caputo, Sl; Bonora, S; Carosi, Giampiero
Influence of hepatitis C virus coinfection on lipid abnormalities in HIV-positive patients after highly active antiretroviral therapy 1-gen-2002 Torti, Carlo; Patroni, A; Tinelli, C; Sleiman, I; QUIROS ROLDAN, Maria Eugenia; Puoti, Massimo; Castelli, Francesco
Is moderate HIV viremia associated with a higher risk of clinical progression in HIV-infected people treated with highly active antiretroviral therapy: evidence from the Italian cohort of antiretroviral-naive patients study 1-gen-2006 Murri, R; Lepri, Ac; Cicconi, P; Poggio, A; Arlotti, M; Tositti, G; Santoro, D; Soranzo, Ml; Rizzardini, G; Colangeli, V; Montroni, M; Monforte, Ad; ICoNA Study Group,
Lipid abnormalities in HIV-infected patients are not correlated with lopinavir plasma concentrations. 1-gen-2004 Torti, Carlo; QUIROS ROLDAN, Maria Eugenia; Regazzi Bonora, M; De Luca, A; Lo Caputo, S; Di Giambenedetto, S; Patroni, A; Villani, P; Micheli, V; Carosi, Giampiero; Resistance, ; Dosage Adapted Regimens Study Group of the MASTER, Cohort
Mortality for liver disease in patients with HIV infection: a cohort study 1-gen-2000 Puoti, Massimo; Spinetti, As; Ghezzi, A; Donato, Francesco; Zaltron, S; Putzolu, V; QUIROS ROLDAN, Maria Eugenia; Zanini, Barbara; Casari, S; Carosi, Giampiero
Natural history of compensated viral cirrhosis in a cohort of patients with HIV infection. 1-gen-2007 Bruno, R; Sacchi, P; Puoti, Massimo; Maiocchi, L; Patruno, S; Carosi, Giampiero; Filice, G.
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 1-gen-2007 Costarelli, Silvia; Torti, Carlo; Gatta, Lb; Tinelli, C; Lapadula, Giuseppe; QUIROS ROLDAN, Maria Eugenia; Izzo, Ilaria; Castelnuovo, F; Biasiotto, Giorgio; Arosio, Paolo; Carosi, Giampiero
Plasma viral load concentrations in women and men from different exposure categories and with known duration of HIV infection 1-gen-2000 Rezza, G; Lepri, Ac; D'ARMINIO MONFORTE, A; Pezzotti, P; Castelli, Francesco; Dianzani, F; Lazzarin, A; DE LUCA, A; Arlotti, M; Leoncini, F; Manconi, Pe; Rizzardini, G; Minoli, L; Poggio, A; Ippolito, G; Phillips, An; Moroni, M.
Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013 1-gen-2014 d'Arminio Monforte, Antonella; Galli, Laura; Lo Caputo, Sergio; Lichtner, Miriam; Pinnetti, Carmela; Bobbio, Nicoletta; Francisci, Daniela; Costantini, Andrea; Cingolani, Antonella; Castelli, Francesco; Girardi, Enrico; Castagna, Antonella
Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort 1-gen-2011 Vescini, F; Cozzi Lepri, A; Borderi, M; Re, Mc; Maggiolo, F; De Luca, A; Cassola, G; Vullo, V; Carosi, Giampiero; Antinori, A; Tozzi, V; Monforte, Ad; Icona Foundation Study Group: Moroni, M; Angarano, G; Antinori, A; Carosi, G; Cauda, R; d'Arminio Monforte, A; Di Perri, G; Galli, M; Iardino, R; Ippolito, G; Lazzarin, A; Perno, Cf; Viale, Pl; Von Schlosser, F; d'Arminio Monforte, A; Ammassari, A; Andreoni, M; Antinori, A; Balotta, C; Bonfanti, P; Bonora, S; Borderi, M; Capobianchi, Mr; Castagna, A; Ceccherini Silberstein, F; Cozzi Lepri, A; d'Arminio Monforte, A; De Luca, A; Gargiulo, M; Gervasoni, C; Girardi, E; Lichtner, M; Lo Caputo, S; Madeddu, G; Maggiolo, F; Marcotullio, S; Monno, L; Murri, R; Mussini, C; Puoti, M; Torti, Carlo; Cozzi Lepri, A; Fanti, I; Formenti, T; Montroni, M; Giacometti, A; Costantini, A; Riva, A; Tirelli, U; Martellotta, F; Angarano, G; Monno, L; Ladisa, N; Suter, F; Maggiolo, F; Viale, Pl; Verucchi, G; Piergentili, B; Carosi, G; Cristini, G; Torti, C; Minardi, C; Bertelli, D; Quirino, T; Abeli, C; Manconi, Pe; Piano, P; Vecchiet, J; Falasca, K; Carnevale, G; Lorenzotti, S; Sighinolfi, L; Leoncini, F; Mazzotta, F; Pozzi, M; Lo Caputo, S; Cassola, G; Viscoli, G; Alessandrini, A; Piscopo, R; Mazzarello, G; Mastroianni, C; Belvisi, V; Bonfanti, P; Molteni, C; Chiodera, A; Castelli, P; Galli, M; Lazzarin, A; Rizzardini, G; Puoti, M; d'Arminio Monforte, A; Ridolfo, Al; Foschi, A; Castagna, A; Salpietro, S; Merli, S; Carenzi, L; Moioli, Mc; Cicconi, P; Formenti, T; Esposito, R; Mussini, C; Gori, A; Pastore, V; Abrescia, N; Chirianni, A; De Marco, M; Ferrari, C; Borghi, R; Baldelli, F; Belfiori, B; Parruti, G; Sozio, F; Magnani, G; Ursitti, Ma; Emilia, R; Arlotti, M; Ortolani, P; Cauda, R; Andreoni, M; Antinori, A; Antonucci, G; Narciso, P; Tozzi, V; Vullo, V; De Luca, A; Zaccarelli, M; Gallo, L; Acinapura, R; De Longis, P; Ceccarelli, L; Libertone, R; Trotta, Mp; Miccoli, A; Cattelan, Am; Mura, Ms; Madeddu, G; Caramello, P; Di Perri, G; Orofino, Gc; Sciandra, M; Raise, E; Ebo, F; Pellizzer, G; Buonfrate, D.
R211K and L214F do not invariably confer high level phenotypic resistance to thymidine analogs in zidovudine-naïve patients with M184V 1-gen-2001 Torti, Carlo; Gilleece, Y.; Hertogs, K.; Gazzard, B. G.; Pozniak, A.
A randomized, pilot trial to evaluate glomerular filtration rate by creatinine or cystatin C in naive HIV-infected patients after tenofovir/emtricitabine in combination with atazanavir/ritonavir or efavirenz 1-gen-2012 Albini, Laura; Cesana, Bruno Mario; Motta, Davide; Foca', Emanuele; Gotti, Daria; Calabresi, A; Izzo, I; Bellagamba, R; Fezza, R; Narciso, P; Sighinolfi, L; Maggi, P; QUIROS ROLDAN, Maria Eugenia; Manili, L; Guaraldi, G; Lapadula, G; Torti, C.
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48 week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial 1-gen-2003 Mazzotta, F.; LO CAPUTO, S.; Torti, Carlo; Tinelli, C.; Pierotti, P.; Castelli, Francesco; Lazzarin, A.; Angarano, G.; Maserati, Renato; Gianotti, N.; Ladisa, N.; QUIROS ROLDAN, Maria Eugenia; Rinehart, A. R.; Carosi, Giampiero
Replication capacity in relation to immunologic and virologic outcomes in HIV-1-infected treatment-naive subjects 1-gen-2009 Skowron, G; Spritzler, Jg; Weidler, J; Robbins, Gk; Johnson, Va; Chan, Es; Asmuth, Dm; Gandhi, Rt; Lie, Y; Bates, M; Pollard, Rb; NIH/NIAID ACTG 384 Protocol, Team; Monogram, Biosciences; Vella, S; Chiesi, C; Arcieri, R; Pirillo, Mf; Galluzzo, Cm; Pia Germinario, Ea; Amici, R; Marzi, M; Nobile, A; Di Nallo, R; Polizzi, C; Coronado, O; Fasulo, G; Carosi, Giampiero; Castelli, Francesco; Di Pietro, M; Vichi Ospedale, F; Sterrantino, G; Ambu, S; Cargnel, A; Meraviglia, P; Niero, F; Capetti, A; d'Arminio Monforte, A; Sollima, S; Balotta, C; Delia, S; Ciardi, M; Soranzo, Ml; Macor, A; D'Ettorre, G; Forcina, G; Bassetti, D; Di Biagio, A; Minoli, L; Maserati, R; Ghinelli, F; Sighinolfi, L; Riva, A; Scalise, G; Santoro, D; Rinaldi, E; Chiodo, F; Borderi, M; Guaraldi, G; Esposito, R; Ferrari, C; Pasetti, G; Abrescia, N; Busto, A; Chirianni, A; Gargiulo, M; Izzo, Cm; Sbreglia, C; Alberici, F; Sacchini, D; Magnani, G; Zoboli, G.
Reversible reduction of nevirapine plasma concentrations during rifampicin treatment in patients coinfected with HIV-1 and tuberculosis 1-gen-2009 Matteelli, Alberto; Saleri, N; Villani, P; Bonkoungou, V; Carvalho, Ac; Kouanda, S; Sanou, Mj; Simporé, J; Monno, L; Carosi, Giampiero; Regazzi, M; Dembele, M.
Risk of Liver Enzyme Elevation During Treatment With Ritonavir-Boosted Protease Inhibitors Among HIV-Monoinfected and HIV/HCV-Coinfected Patients 1-gen-2015 Lapadula, Giuseppe; Costarelli, Silvia; Chatenoud, Liliane; Castelli, Francesco; Astuti, Noemi; Di Giambenedetto, Simona; QUIROS ROLDAN, Maria Eugenia; Sighinolfi, Laura; Ladisa, Nicoletta; Di Pietro, Massimo; Zoncada, Alessia; Di Filippo, Elisa; Gori, Andrea; Nasta, Paola; Torti, Carlo
Role of Normalized T-Cell Subsets in Predicting Comorbidities in a Large Cohort of Geriatric HIV-Infected Patients 1-gen-2017 Calcagno, Andrea; Piconi, Stefania; Focà, Emanuele; Nozza, Silvia; Carli, Federica; Montrucchio, Chiara; Cattelan, Annamaria M.; Orofino, Giancarlo; Celesia, Benedetto M.; Morena, Valentina; De Socio, Giuseppe V.; Guaraldi, Giovanni
Severe hepatotoxicity during combination antiretroviral treatment: incidence, liver histology, and outcome. 1-gen-2003 Puoti, M; Torti, C; Ripamonti, D; Castelli, F; Zaltron, S; Zanini, B; Spinetti, A; Putzolu, V; Casari, S; Tomasoni, L; Quiros Roldan, E; Favret, M; Berchich, L; Grigolato, Pier Giovanni; Callea, F; Carosi, G; HIV HCV Co Infection Study, Group
Mostrati risultati da 15 a 34 di 41
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile